Table 3

Genes differentially expressed in CD4+CD56+HN versus c-AML

Fold changeDescriptionGene symbolDistribution of expression according to GNF SymAtlas
BDCA4+ dendritic cellsCentral nervous systemBM CD33+ myeloid cells
    449.97 T-cell leukemia/lymphoma 1A TCL1A*   
    255.10 Immunoglobulin lambda-like polypeptide 1 IGLL1    
    138.92 Sodium channel, voltage-gated, type III, alpha SCN3A*   
    109.07 B-cell novel protein 1 BCNP1*   
    69.38 Spi-B transcription factor (Spi-1/PU.1 related) SPIB   
    37.01 Hairy and enhancer of split 6 (Drosophila) HES6*    
    35.20 Serine hydrolase-like 2 SERHL2   
    34.48 Hypothetical protein FLJ20716 FLJ20716   
    29.86 Cyclic AMP-regulated phosphoprotein, 21 kDa ARPP-21   
    29.00 RAS, dexamethasone-induced 1 RASD1  
    28.85 Sidekick homolog 2 (chicken) SDK2   
    28.64 Proapoptotic caspase adaptor protein PACAP*   
    25.91 Chromosome 14 open reading frame 175 C14orf175 NA NA NA 
    24.61 Fc receptor homolog expressed in B cells FREB   
    24.25 Deoxynucleotidyltransferase, terminal TdT    
23.56 Sialic acid binding Ig-like lectin 6 (CD33-like1) SIGLEC6*    
    23.33 WAS protein family, member 1 WASF1*   
    21.96 Thymosin-like 8 TMSL8   
    21.07 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 PFKFB2   
    20.69 Interleukin-28 receptor, alpha (interferon, lambda receptor) IL28RA    
    20.32 Hypothetical protein LOC158402 LOC158402 NA NA NA 
    19.56 KIAA0746 protein KIAA0746   
    19.21 B-cell linker BLNK   
    19.13 Potassium channel, subfamily K, member 17 KCNK17   
    18.96 Protein tyrosine phosphatase, receptor type, S PTPRS   
    18.64 G protein-coupled receptor 160 GPR160*    
    18.14 Napsin B aspartic peptidase pseudogene NAPSB   
    18.08 Brain expressed X-linked 2 BEX2   
    17.77 Troponin I, skeletal, fast TNNI2    
17.20 Runt-related transcription factor 2 RUNX2*    
    16.23 Hypothetical LOC339541 MGC33556   
    16.08 Chromosome 18 open reading frame 1 C18orf1   
    15.96 Serine hydrolase-like SERHL   
    15.91 B-cell CLL/lymphoma 11A (zinc finger protein) BCL11A   
    15.47 Immunoglobulin J polypeptide IGJ   
    14.75 Core-binding factor, runt domain, alpha subunit 2; transl. 3 CBFA2T3*   
    14.69 Adenosine deaminase ADA   
    14.02 T-cell receptor alpha locus /// T-cell receptor delta locus TRA /// TRD   
    13.71 Myosin VI MYO6   
    13.41 PDZ domain containing RING finger 3 PDZRN3   
    12.97 Solute carrier family 38, member 1 SLC38A1   
    12.06 Fas apoptotic inhibitory molecule FAIM3   
    11.98 Selectin L (lymphocyte adhesion molecule 1) SELL   
    11.06 Chromosome 3 open reading frame 6 C3orf6   
    11.05 UDP-glucose ceramide glucosyltransferase UGCG*   
    10.42 SRY (sex determining region Y)-box 4 SOX4   
    10.00 Protein phosphatase 1K (PP2C domain containing) PPM1K   
    0.02 C-type lectin domain family 5, member A CLEC5A*   
    0.03 Myeloid-cell nuclear differentiation antigen MNDA   
    0.04 C-type lectin domain family 7, member A CLEC7A   
    0.04 Regulator of G-protein signaling 18 RGS18   
    0.04 Hypothetical protein FLJ33069 FLJ33069   
    0.05 V-set and immunoglobulin domain containing 4 VSIG4    
    0.05 Chemokine (C-X3-C motif) receptor 1 CX3CR1    
    0.05 Ficolin (collagen/fibrinogen domain containing) 1 FCN1   
    0.05 Cathepsin G CTSG    
    0.06 CD33 antigen (gp67) CD33*   
    0.06 Calcium channel, voltage-dependent, alpha 2/delta subunit 4 CACNA2D4    
    0.06 Fc fragment of IgG, high affinity Ia, receptor (CD64) FCGR1A   
    0.08 Toll-like receptor 8 TLR8   
    0.08 Complement component 3a receptor 1 C3AR1   
    0.09 Potassium voltage-gated channel, Isk-related family, member 3 KCNE3   
    0.10 CD14 antigen CD14   
Fold changeDescriptionGene symbolDistribution of expression according to GNF SymAtlas
BDCA4+ dendritic cellsCentral nervous systemBM CD33+ myeloid cells
    449.97 T-cell leukemia/lymphoma 1A TCL1A*   
    255.10 Immunoglobulin lambda-like polypeptide 1 IGLL1    
    138.92 Sodium channel, voltage-gated, type III, alpha SCN3A*   
    109.07 B-cell novel protein 1 BCNP1*   
    69.38 Spi-B transcription factor (Spi-1/PU.1 related) SPIB   
    37.01 Hairy and enhancer of split 6 (Drosophila) HES6*    
    35.20 Serine hydrolase-like 2 SERHL2   
    34.48 Hypothetical protein FLJ20716 FLJ20716   
    29.86 Cyclic AMP-regulated phosphoprotein, 21 kDa ARPP-21   
    29.00 RAS, dexamethasone-induced 1 RASD1  
    28.85 Sidekick homolog 2 (chicken) SDK2   
    28.64 Proapoptotic caspase adaptor protein PACAP*   
    25.91 Chromosome 14 open reading frame 175 C14orf175 NA NA NA 
    24.61 Fc receptor homolog expressed in B cells FREB   
    24.25 Deoxynucleotidyltransferase, terminal TdT    
23.56 Sialic acid binding Ig-like lectin 6 (CD33-like1) SIGLEC6*    
    23.33 WAS protein family, member 1 WASF1*   
    21.96 Thymosin-like 8 TMSL8   
    21.07 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 PFKFB2   
    20.69 Interleukin-28 receptor, alpha (interferon, lambda receptor) IL28RA    
    20.32 Hypothetical protein LOC158402 LOC158402 NA NA NA 
    19.56 KIAA0746 protein KIAA0746   
    19.21 B-cell linker BLNK   
    19.13 Potassium channel, subfamily K, member 17 KCNK17   
    18.96 Protein tyrosine phosphatase, receptor type, S PTPRS   
    18.64 G protein-coupled receptor 160 GPR160*    
    18.14 Napsin B aspartic peptidase pseudogene NAPSB   
    18.08 Brain expressed X-linked 2 BEX2   
    17.77 Troponin I, skeletal, fast TNNI2    
17.20 Runt-related transcription factor 2 RUNX2*    
    16.23 Hypothetical LOC339541 MGC33556   
    16.08 Chromosome 18 open reading frame 1 C18orf1   
    15.96 Serine hydrolase-like SERHL   
    15.91 B-cell CLL/lymphoma 11A (zinc finger protein) BCL11A   
    15.47 Immunoglobulin J polypeptide IGJ   
    14.75 Core-binding factor, runt domain, alpha subunit 2; transl. 3 CBFA2T3*   
    14.69 Adenosine deaminase ADA   
    14.02 T-cell receptor alpha locus /// T-cell receptor delta locus TRA /// TRD   
    13.71 Myosin VI MYO6   
    13.41 PDZ domain containing RING finger 3 PDZRN3   
    12.97 Solute carrier family 38, member 1 SLC38A1   
    12.06 Fas apoptotic inhibitory molecule FAIM3   
    11.98 Selectin L (lymphocyte adhesion molecule 1) SELL   
    11.06 Chromosome 3 open reading frame 6 C3orf6   
    11.05 UDP-glucose ceramide glucosyltransferase UGCG*   
    10.42 SRY (sex determining region Y)-box 4 SOX4   
    10.00 Protein phosphatase 1K (PP2C domain containing) PPM1K   
    0.02 C-type lectin domain family 5, member A CLEC5A*   
    0.03 Myeloid-cell nuclear differentiation antigen MNDA   
    0.04 C-type lectin domain family 7, member A CLEC7A   
    0.04 Regulator of G-protein signaling 18 RGS18   
    0.04 Hypothetical protein FLJ33069 FLJ33069   
    0.05 V-set and immunoglobulin domain containing 4 VSIG4    
    0.05 Chemokine (C-X3-C motif) receptor 1 CX3CR1    
    0.05 Ficolin (collagen/fibrinogen domain containing) 1 FCN1   
    0.05 Cathepsin G CTSG    
    0.06 CD33 antigen (gp67) CD33*   
    0.06 Calcium channel, voltage-dependent, alpha 2/delta subunit 4 CACNA2D4    
    0.06 Fc fragment of IgG, high affinity Ia, receptor (CD64) FCGR1A   
    0.08 Toll-like receptor 8 TLR8   
    0.08 Complement component 3a receptor 1 C3AR1   
    0.09 Potassium voltage-gated channel, Isk-related family, member 3 KCNE3   
    0.10 CD14 antigen CD14   

Genes differentially expressed in CD4+CD56+HN versus c-AML resulting from supervised analysis applying a fold change difference of at least 10. Expression distribution according to the Genomics Institute of the Novartis Research Foundation (GNF) SymAtlas is indicated (X). Bold indicates genes seemingly characteristic for CD4+CD56+HN (for details see “Putative oncogenes” and “Novel membrane-bound markers for CD4+CD56+HN”).

NA indicates not available.

*

Genes verified by real-time RT-PCR.

Close Modal

or Create an Account

Close Modal
Close Modal